News (Proprietary)
Yellow Pages GAAP EPS of C$0.29, revenue of C$48.34M (Pink Current Info:YLWDF)
2+ week, 3+ day ago (89+ words) Founded in 2004, Seeking Alpha is an industry-leading financial research platform powered by one of the world's largest investing communities. We bridge the gap between financial information and actionable insight by providing unrivaled coverage on all asset classes and access to best-in-class tools. From in-depth analysis on thousands of stocks to timely investment ideas and market-beating Quant ratings*, Seeking Alpha is an essential resource for millions of investors globally. - Yellow Pages press release (OTCPK:YLWDF): Q3 GAAP EPS of C$0.29. More on Yellow Pages...
2+ week, 5+ day ago (91+ words) Founded in 2004, Seeking Alpha is an industry-leading financial research platform powered by one of the world's largest investing communities. We bridge the gap between financial information and actionable insight by providing unrivaled coverage on all asset classes and access to best-in-class tools. From in-depth analysis on thousands of stocks to timely investment ideas and market-beating Quant ratings*, Seeking Alpha is an essential resource for millions of investors globally. - Sunrise Communications AG press release (OTC:SNREY): Q3 Net loss of CHF4.4M More on Sunrise Communications AG...
3+ week, 5+ day ago (123+ words) Founded in 2004, Seeking Alpha is an industry-leading financial research platform powered by one of the world's largest investing communities. We bridge the gap between financial information and actionable insight by providing unrivaled coverage on all asset classes and access to best-in-class tools. From in-depth analysis on thousands of stocks to timely investment ideas and market-beating Quant ratings*, Seeking Alpha is an essential resource for millions of investors globally. - Eve Holding press release (EVEX): Q3 GAAP EPS of -$0.14 beats by $0.02. - Eve reported a net loss of $46.9 million in 3Q25, compared to $35.8 million in 3Q24. The increase in net loss in 3Q25 was primarily driven by higher Research & Development (R&D) expenses, which are costs...
Personalis Reports Third Quarter 2025 Financial Results (2025-11-04)
3+ week, 5+ day ago (374+ words) Company Advances "Win-in-MRD" Strategy with Compelling Clinical Trial Data and Increasing Physician Adoption of NeXT Personal" Platform FREMONT, Calif.--(BUSINESS WIRE)-- Personalis, Inc. (PSNL), a leader in advanced genomics for precision oncology, today reported financial results for the third quarter ended September 30, 2025. The quarter was distinguished by significant operational momentum in its "Win-in-MRD" strategy, headlined by increasing clinical tests delivered and robust clinical evidence generation. Third Quarter 2025 and Recent Business Highlights Third Quarter 2025 Financial Results Compared with 2024 Revenue of $14.5 million for the third quarter of 2025 compared with $25.7 million. The decrease of 44% was primarily due to the expected decline of $4.6 million in revenue from Natera, a decrease in population sequencing revenue of $4.2 million, and a decrease in revenue from pharma tests and services, and other customers of $2.5 million. Fourth Quarter and Full Year 2025 Outlook Personalis expects the following for the fourth…...
LifeMD outlines $192M-$193M 2025 revenue target amid margin shifts and expansion into women's and behavioral health (NASDAQ:LFMD)
1+ week, 5+ day ago (110+ words) Founded in 2004, Seeking Alpha is an industry-leading financial research platform powered by one of the world's largest investing communities. We bridge the gap between financial information and actionable insight by providing unrivaled coverage on all asset classes and access to best-in-class tools. From in-depth analysis on thousands of stocks to timely investment ideas and market-beating Quant ratings*, Seeking Alpha is an essential resource for millions of investors globally. Earnings Call Insights: LifeMD, Inc. (LFMD) Q3 2025 How will LifeMD's strategic shift impact growth in 2026? What are the main financial risks for LifeMD in weight management? How could insurance enablement affect LifeMD's operating performance?...
Medicenna Therapeutics GAAP EPS of -C$0.06 (OTCQB:MDNAF)
2+ week, 3+ day ago (119+ words) Founded in 2004, Seeking Alpha is an industry-leading financial research platform powered by one of the world's largest investing communities. We bridge the gap between financial information and actionable insight by providing unrivaled coverage on all asset classes and access to best-in-class tools. From in-depth analysis on thousands of stocks to timely investment ideas and market-beating Quant ratings*, Seeking Alpha is an essential resource for millions of investors globally. - Medicenna Therapeutics press release (OTCQB:MDNAF): Q2 GAAP EPS of -C$0.06. Medicenna exited the quarter ended September 30, 2025, with cash and cash equivalents of C$15.7 million. These funds are expected to provide the Company with sufficient capital to execute its current planned expenditures through...
Apyx Medical outlines $50.5M–$52.5M 2025 revenue target, signals AYON launch momentum (NASDAQ:APYX)
3+ week, 3+ day ago (111+ words) Founded in 2004, Seeking Alpha is an industry-leading financial research platform powered by one of the world's largest investing communities. We bridge the gap between financial information and actionable insight by providing unrivaled coverage on all asset classes and access to best-in-class tools. From in-depth analysis on thousands of stocks to timely investment ideas and market-beating Quant ratings*, Seeking Alpha is an essential resource for millions of investors globally. How is Apyx Medical's AYON Body Contouring System impacting financial results? What is Apyx Medical's updated revenue outlook for 2025 and its key drivers? How does management view market demand and growth opportunities for Surgical Aesthetics?...
Minerva Neurosciences GAAP EPS of -$0.36 (NASDAQ:NERV)
3+ week, 4+ day ago (88+ words) Founded in 2004, Seeking Alpha is an industry-leading financial research platform powered by one of the world's largest investing communities. We bridge the gap between financial information and actionable insight by providing unrivaled coverage on all asset classes and access to best-in-class tools. From in-depth analysis on thousands of stocks to timely investment ideas and market-beating Quant ratings*, Seeking Alpha is an essential resource for millions of investors globally. - Minerva Neurosciences press release (NERV): Q3 GAAP EPS of -$0.36. More on Minerva Neurosciences...
Regional Health Properties GAAP EPS of $1.17, revenue of $15.14M (OTCMKTS:RHEP)
1+ week, 2+ day ago (86+ words) Founded in 2004, Seeking Alpha is an industry-leading financial research platform powered by one of the world's largest investing communities. We bridge the gap between financial information and actionable insight by providing unrivaled coverage on all asset classes and access to best-in-class tools. From in-depth analysis on thousands of stocks to timely investment ideas and market-beating Quant ratings*, Seeking Alpha is an essential resource for millions of investors globally. - Regional Health Properties press release (OTC:RHEP): Q3 GAAP EPS of $1.17....
Service Corporation International (SCI) Presents at UBS Global Healthcare Conference 2025 Transcript
2+ week, 5+ day ago (127+ words) Service Corporation International (SCI) UBS Global Healthcare Conference 2025 November 11, 2025 1:15 PM EST Aaron Foley - Senior VP & Treasurer Albert Rice - UBS Investment Bank, Research Division So hello, everybody. Thanks for the next presentation. We have Service Corp International, and we're very pleased to have Aaron Foley, Senior Vice President and Treasurer; Andrea Low, Director of Investor Relations. So Aaron, thanks for doing this again this year. We're 10 months into the year. What are some of the things you highlight as surprises, positives, challenges that the company has faced. How would you sum up the year up to this point? Aaron FoleySenior VP & Treasurer And I think that we should see continued foundational strength from here going forward. So I'd consider that...